DASGIP Launches Micro-bioreactor for High Throughput Screening

DASGIP AG, a leading manufacturer of parallel bioreactor systems, announced the launch of a miniature bioreactor system for high throughput screening at Biotechnica, 9 – 11 October 2007, in Hanover, Germany. The "DASGIP BioLector" has been developed by m2p-labs, Aachen, Germany, who entered into a partnership with DASGIP to bring the new product to market. Under the agreement, DASGIP has marketing rights in North-America and in Europe.

The DASGIP BioLector monitors cell growth and protein production in up to 96 wells online and in parallel. Additionally, pH or dissolved oxygen can be monitored in each well. Continuous shaking allows uninterrupted aeration by gas exchange between the cells and their environment. The BioLector provides an ideal gas atmosphere for different cell types.

With DASGIP BioLector, operators are able to screen multiple cell lines or strains for growth and expression levels in parallel. Working volumes of the 48- and 96-well plates range from 100μL to 1000 μL per well. Once the candidates of interest are selected, a tailored process can be developed and optimized in DASGIP Parallel Bioreactor Systems, which provide working volume from 35mL to 15L in up to 16 bioreactors in parallel. Therefore, the new parallel screening tool not only makes product development more efficient, but also rounds up DASGIP’s existing fermentation and cultivation solutions perfectly.

”Customers using the DASGIP systems will benefit extraordinarily in process development. With the
new BioLector they benefit from higher efficiency in earlier phases of their value chain”, Dr. Matthias Arnold, CSO DASGIP. The figure above shows how DASGIP products improve and streamline research and process development.